This 2017 data brief from the Prescription Behavior Surveillance System compares trends in synthetic opioid overdose deaths in 5 states to trends in law enforcement reports on fentanyl and prescriptions for fentanyl in those states. A product of the Prescription Drug Monitoring Program Center of Evidence at Brandeis University.
This brief describes the purpose of the Prescription Behavior Surveillance System (PBSS) project at the Prescription Drug Monitoring Program (PDMP) Center of Excellence at Brandeis University. The PBSS collects data from state PDMPs and analyzes the data to guide state policy decisions regarding prescription controlled substances.
This 4 page document briefly summarizes the Centers for Medicare & Medicaid Services strategy for fighting the opioid crisis including their initiatives in prevention, treatment, and data analysis.
The Prescription Behavior Surveillance System (PBSS) collects deindentified data from state prescription drug monitoring programs (PDMPs) to identify trends in controlled substance prescribing and dispensing and indicators of non-medical use and diversion. This 2015 report summarizes the data from Maine’s PDMP.
The Prescription Behavior Surveillance System (PBSS) collects deindentified data from state prescription drug monitoring programs (PDMPs) to identify trends in controlled substance prescribing and dispensing and indicators of non-medical use and diversion. This 2016 report summarizes the data from Idaho’s PDMP.
The Prescription Behavior Surveillance System (PBSS) collects deindentified data from state prescription drug monitoring programs (PDMPs) to identify treads in controlled substance prescribing and dispensing and indicators of non-medical use and diversion. This 2016 report looks at the
The 2018 Arizona regulations that codify the requirements that law enforcement, emergency medical responders, health care providers and health care facilities must report incidences of opioid overdoses, deaths due to opioid overdoses, and the number of naloxone doses dispensed and administered.
Funding Source: Arizona Department of Health Services
This is the website for the Arizona enhanced opioid surveillance data project. It provides real time data on a variety of opioid topics including overdose, use of naloxone, neonatal withdrawal syndrome (or neonatal abstinence syndrome), and reports based on age, gender, and geographic location.
The Arizona State Public Health Laboratory has created a program to screen blood samples from individuals with a suspected opioid overdose in order to better understand which opioids are responsible for causing overdoses in the state. Health care providers and institutions can request a courier to pick up samples which are then tested for the qualitative identification of opioids, fentanyl analogs, benzodiazepines, stimulants, cannabinoids, and synthetic cannabinoids. This is the Arizona Department of Health Services website for the laboratory testing program.